Tuesday, June 30, 2020

Supreme Court of Canada Rules Against Uber in $400M Class Action, Delivers Historic Win for Employees
Samfiru Tumarkin LLP

TORONTO, June 26, 2020 /CNW/ - Today, the Supreme Court of Canada issued a historical decision on a class action lawsuit against Uber that preserves employee rights across the country.

The court found that, in the case of Heller v. Uber Technologies Inc., the $400 million lawsuit must be heard in Ontario, and not through international arbitration in the Netherlands as proposed by Uber.

"The Supreme Court of Canada's message is very clear: if you wish to operate in this country, you have to be prepared to abide by the laws of Canada and adhere to the jurisdiction of its courts," said employment lawyer Lior Samfiru of Samfiru Tumarkin LLP, who commenced the class action in 2017 on behalf of Uber drivers.

The lawsuit alleges that the drivers were employees at law, that they were misclassified as independent contractors by Uber, and were therefore owed various entitlements under Ontario and Canadian employment laws.


The issue before The Supreme Court of Canada was whether Uber was able to require its drivers to arbitrate any and all disputes in the Netherlands. Upon signing up with Uber, drivers were required to sign a document purporting to require them to raise any dispute with Uber before an international arbitration in Amsterdam. Uber, therefore, tried to have the lawsuit dismissed saying the drivers cannot proceed with legal action in Canada but must file individual arbitrations in a foreign country.

The concern with Uber's position was that, if a company can require its workers to only raise dispute in a foreign jurisdiction, no worker would actually take such a step, which would allow a company to do whatever it wanted, without repercussions.

"A win for Uber would have effectively ended employee rights in this country," said Samfiru. "The Supreme Court of Canada was well aware of this issue and determined that a company operating in Canada must abide by Canadians laws and cannot eliminate employee rights by imposing the laws of a foreign jurisdiction."
The Supreme Court reiterated that employees and all workers continue to have access to legal tribunals and Canadian courts in order to enforce their rights.

"After all, all the legal rights in the world are of no value if there is no way to enforce them. For a company to try to require employees to give up the laws of Canada is unconscionable and offends our sense of fairness and common sense," said Samfiru.

Uber now will have to address the claims of the drivers that they are employees and have been misclassified for many years.


About Samfiru Tumarkin LLP

Samfiru Tumarkin LLP is an employment law firm that specializes in severance pay, wrongful dismissal, denied long term disability claims, constructive dismissal, employee misclassification, human rights law, labour law, temporary layoffs and employment contracts.

The firm represents both employees and employers across Ontario and British Columbia, as well as individuals who have been denied their long-term disability payments by the insurance company. It has successfully represented tens of thousands of clients in Ontario and BC combined, and is the most positively reviewed employment law firm in Canada (on Google).

SOURCE Samfiru Tumarkin LLP

For further information: Lior Samfiru, Partner at Samfiru Tumarkin LLP, lior.samfiru@stlawyers.ca, 416-216-5900; or Ryan Bonnar, Media Relations Manager at Samfiru Tumarkin LLP, ryan.bonnar@stlawyers.ca, 416-216-5893
Related Links

http://stlawyers.ca/toronto/
Lack of Access to Vision Loss Costs Canadians $19 billion per year

Canadian Ophthalmological Society

OTTAWA, ON, June 26, 2020 /CNW/ - Despite concerted action over the past 30 years, Canadian and health systems worldwide face significant challenges in meeting the current and projected eye care needs.

Vision loss costs Canadians $19 billion/year and the impact of major eye diseases and trauma disproportionately impact minority communities in Canada. The federal government signed the World Health Organization's first resolution on Universal Eye Health that will be presented at the next World Health Assembly this year, however, Canada has not taken any action to increase vision health access in our country.

The Canadian Ophthalmological Society (COS) hosted the national launch of the World Health Organization's first World Report on Vision is calling upon the Canadian government to take action. "The federal government should extend universal access to government-funded eye services for Canadians of all ages; to eliminate barrier to access for medically necessary eye drugs; eliminate drug shortages for critical eye care medicines; and expand public infrastructure for tele-ophthalmology," Said Dr. Yvonne Buys, President of the COS, "Still too many Canadians suffer from preventable or treatable vision loss at a substantial cost to them individually and us as a society."

World Health Organization's first World Report on Vision outlines the magnitude of the problem where at least 1 billion people around the world currently live with vision loss that could have been prevented. The WHO has called for governments to make eye care an integral part of universal health coverage; implement integrated people-centred eye care in health systems; promote high-quality research; monitor trends and evaluate progress; raise awareness, and engage and empower people and communities.

About the Canadian Ophthalmological Society
The Canadian Ophthalmological Society (COS) is the national, recognized authority on eye and vision care in Canada. As eye physicians and surgeons, we are committed to assuring the provision of optimal medical and surgical eye care for all Canadians by promoting excellence in ophthalmology and by providing services to support our members in practice. Our membership includes over 900 ophthalmologists and 200 ophthalmology residents. We work collaboratively with government, other national and international specialty societies, our academic communities (ACUPO), our provincial partners and affiliates and other eye care professionals and patient groups to advocate for health policy in Canada in the area of eye and vision health. COS is an accredited, award-winning provider of Continuing Professional Development (CPD) through the Royal College of Physicians and Surgeons of Canada (RCPSC) and is an affiliate of the Canadian Medical Association (CMA). For more information, visit cos-sco.ca.

SOURCE Canadian Ophthalmological Society

For further information: The PR Department Inc., Cell: 416-948-7417, medias@prdepartment.ca

Organization Profile

Canadian Ophthalmological Society


Also from this source


Vision Health and Covid-19 Update from the Canadian...
Vancouver-based NGO Backs the Call for Canadian Government to Increase Equitable Access to Eye Care as Recommended by the World Health Organization's First-ever World Report on Vision 



Seva Canada Society

VANCOUVER, BC, June 26, 2020 /CNW/ - Vancouver-based eye care charity, Seva Canada, co-hosted the launch of the World Health Organization's (WHO) first World Report on Vision in Canada on June 26, 2020. The cost of vision loss to Canadians is $19 billion/year and affects all elements of our economy. Costs are expected to rise to $30.3 billion/year by 2032 with the overall single largest indirect cost being lost productivity. Canada, a signatory to the WHO's first resolution on Universal Eye Health has not taken any significant action to address vision health. Seva Canada, along with the Canadian eye care community, called upon the Canadian government to take a leadership role to implement the recommendations of the World Health Organization's first World Report on Vision, launched by the Director-General Dr. Tedros Adhanom Ghebreyesus.

Despite concerted action over the past 30 years, health systems in Canada and worldwide, face significant challenges meeting current and projected eye care needs. Globally more than 2.2 billion people have vision impairment and of those, at least 1 billion have vision impairment that could have been prevented or has yet to be treated. The burden of most eye conditions and vision impairment is not borne equally. It weighs more heavily on low- and middle-income countries, on rural communities, on older people, women, people with disabilities, ethnic minorities and indigenous populations.

With global demand for eye care set to triple by 2050 due to population growth, ageing and changes in lifestyle, recommended actions based on the Word Report on Vision hope to avoid a considerable challenge to Canadian and health systems worldwide.

"Seva Canada is reassured that the WHO is stimulating action to meet growing eye care needs in Canada and globally through an integrated people-centred approach. We know that poverty reduction and the overall health of populations rely on equitable access to eye care. Over the past 38 years, our award-winning development model has been creating sustainable eye care programs in low-income countries with local partners to reach marginalized populations most in need – women, children and people living in extreme poverty and isolation. Everything we do, from training to providing supplies to conducting research and funding surgery, glasses and medicine, is for one reason: to provide communities with access to high-quality care that will restore sight and prevent blindness, now and in the future. When you give people the power of sight, you also give access to education, employment and the foundation for a better life." says Penny Lyons, Seva Canada Executive Director.

Seva Canada and the Canadian eye care community is advocating for the federal and provincial governments to provide universal access to government-funded eye services for Canadians of all ages; to eliminate barriers to access for medically necessary eye medications; eliminate drug shortages for critical eye medications; and to expand public infrastructure for telemedicine for vision care which can provide access to care amongst our rural and indigenous populations.

"People who need eye care must be able to receive high-quality interventions without suffering financial hardship. It is time to make sure that as many people as possible in all countries can see as well as current health technologies and health systems allow." says Director-General Dr. Tedros Adhanom Ghebreyesus.

About Seva Canada: Seva Canada (seva.ca) is a Vancouver-based charitable organization that restores sight and prevents blindness in developing countries. Since 1982, Seva has given over 5 million people the power of sight through life-changing surgeries and provided eye care services including glasses and medicine to millions more.

Seva works with local partners to create sustainable eye care programs that achieve long-term change, are culturally sensitive and reach those most in need – women, children and people living in extreme poverty and isolation. Registered charity #13075 4941 RR0001

SOURCE Seva Canada Society http://www.seva.ca




Government of Canada announces emergency support for Vancouver Aquarium

Funding to Ocean Wise Conservation Association will help ensure the survival of this important tourist attraction and over 70,000 marine animals

Western Economic Diversification Canada 

VANCOUVER, BC, June 26, 2020 /CNW/ - The COVID-19 pandemic has had a significant impact on organizations of all sizes, forcing the closure of important businesses and tourist attractions across Canada. These closures have hurt revenues and forced many to issue layoffs and make difficult choices. That's why the Government of Canada has taken strong action to protect jobs, stabilize our economy and provide relief through this difficult period.

$2 million to support essential services at the Vancouver Aquarium and ensure the survival of 70,000 resident marine animals (CNW Group/Western Economic Diversification Canada)

As it reopens to visitors, Terry Beech, Parliamentary Secretary to the Minister of Fisheries and Oceans and the Canadian Coast Guard, on behalf of the Honourable Mélanie Joly, Minister of Economic Development and Official Languages, and Minister responsible for Western Economic Diversification Canada, today announced emergency federal support for the Vancouver Aquarium.

Federal support for iconic BC tourist attraction affected by COVID-19

Totaling $2 million, this federal funding will support essential services at the aquarium, assisting it through the recovery period. This will help it to reopen to visitors, cover operational costs and ensure the survival of its marine animals.

Operated by the Ocean Wise Conservation Association, the Vancouver Aquarium has been an iconic BC attraction for over 60 years, thrilling residents of the Lower Mainland and tourists from around the world. Yet COVID-19 has resulted in its closure over the past few months, hurting revenues, imperiling jobs and threatening the aquarium's ability to provide for the thousands of animals in its care.

The Government of Canada is committed to providing the support and resources needed to ensure that British Columbia remains a world-leading tourist destination.

Quick facts:
Operated by the OWCA, the Vancouver Aquarium is a marquee tourist attraction offering a rich mixture of marine conservation, education and scientific programming, and is Canada's only marine mammal rescue facility.
The Vancouver Aquarium is home to thousands of ocean species, including rescued seals, sea lions and otters.
According to Destination BC, the tourism industry in British Columbia generated $20.5 billion in revenue in 2018 and employed 161,500 people.

Quotes

"From majestic sharks to adorable sea lions, it's not hard to see why the Vancouver Aquarium is one of British Columbia's most beloved tourist attractions. While COVID-19 has had a serious impact on tourism, this significant support from Western Economic Diversification Canada will help the aquarium keep delighting visitors from across the Lower Mainland and around the world. Our message to the tourism industry is clear: we're working with you to support good jobs and help BC tourism come back strong."
- The Honourable Mélanie Joly, Minister of Economic Development and Official Languages, and Minister responsible for Western Economic Diversification Canada

"Before the COVID-19 pandemic began, over 1 million visitors a year experienced the rich mixture of education and scientific programming offered by the Vancouver Aquarium. This funding will allow the Ocean Wise Conservation Association to continue inspiring the next generation of environmental stewards while providing the critical conservation work that keeps our oceans safe."
- Terry Beech, Parliamentary Secretary to the Minister of Fisheries and Oceans and the Canadian Coast Guard and Member of Parliament for Burnaby North – Seymour

"British Columbia's tourism sector has been hard hit by COVID-19 pandemic and needs help to recover in time for Canadians to explore their communities this summer and beyond. That is why we are providing targeted support to facilities like the Vancouver Aquarium that help attract visitors and support our local economy. We will continue to make every effort to keep Canadians safe while helping communities rebuild in the post-COVID-19 economy."
- Terry Duguid, Parliamentary Secretary to the Minister of Economic Development and Official Languages (Western Economic Diversification Canada) and to the Minister of Environment and Climate Change (Canada Water Agency)

"Ocean Wise is very grateful to the federal government for this emergency funding. Since closing the not-for-profit Vancouver Aquarium in March due to COVID-19, we lost almost all revenues while still being faced with more than $1 million a month in animal care and facility costs. We are still fighting for the Vancouver Aquarium's long-term survival, but this support from Western Economic Diversification Canada is crucial. We are hopeful that the community will continue to support the 64-year-old Vancouver Aquarium, by buying a ticket and coming back to visit us, once we reopen to the public on June 26th."
- Lasse Gustavsson, President and CEO, Ocean Wise Conservation Association

Additional links
Ocean Wise Conservation Association
Vancouver Aquarium

Follow the department on Twitter: @WD_Canada

WD Homepage
WD Toll-Free Number: 1-888-338-WEST (9378)
TTY (telecommunications device for the hearing impaired): 1-877-303-3388

IF THERE IS A DISCREPANCY BETWEEN ANY PRINTED VERSION AND THE ELECTRONIC VERSION OF THIS NEWS RELEASE, THE ELECTRONIC VERSION WILL PREVAIL.

SOURCE Western Economic Diversification Canada

For further information: Alexander Cohen, Press Secretary, Office of the Minister of Economic Development and Official Languages, alexander.cohen@canada.ca; Amanda Costa, A/Regional Communications Manager, Western Economic Diversification Canada, Vancouver, British Columbia, 604-603-9480, amanda.costa@canada.ca
Related Links

http://www.wd.gc.ca/


Organization Profile

Western Economic Diversification Canada


Also from this source


COVID-19: Canadian Seafood Stabilization Fund opens June 22, 2020 ...


Western Economic Diversification Canada working with tourism...


COVID-19: Western Economic Diversification Canada launches...


CANADA HOME OF PSYCHEDELICS SINCE 1948
MindMed Building Diverse Pipeline and Leadership Position in Psychedelic Inspired Medicines Industry




Mind Medicine (MindMed) Inc.

MindMed Co-founders and Co-CEOs JR Rahn and Stephen Hurst to provide corporate update of activities and investor Q&A on July 2, 2020 at 1pm EDT

NEW YORK, June 26, 2020 /CNW/ -- MindMed, the leading neuro-pharmaceutical company for psychedelic inspired medicines is rapidly advancing its drug development pipeline and R&D activities since its listing on March 3, 2020.

MindMed Co-Founder and Co-CEO JR Rahn said, "Our progress in the past few months clearly demonstrates the quality of our team and the pace at which we operate as a company. We are honored to pioneer the fast growing psychedelic inspired medicines industry alongside peers including COMPASS Pathways, ATAI Life Sciences and non-profits MAPs, USONA and the Heffter Institute. There is a very clear distinction of the caliber of organizations advancing clinical trials to develop disruptive medicines for mental health and addiction and we look forward to continually raising the bar for the entire space and patients."

In furtherance of its mission to discover, develop and deploy psychedelic inspired medicines the company and management have executed on the below selected opportunities since listing on March 3, 2020:

LSD (lysergic acid diethylamide)
Experiential Therapies
Added an ongoing Phase 2 clinical trial evaluating high dose LSD for the treatment of anxiety disorders in collaboration with the University Hospital Basel's Liechti Lab.
Initiated Project Lucy, a high dose LSD psychedelic assisted therapy drug commercial development program for the treatment of anxiety disorders, intending to undertake a Phase 2b human trial.
Added and began treating patients in a Phase 2 clinical trial of LSD for Cluster Headaches in collaboration with University Hospital Basel's Liechti Lab.
Filed a patent application for a LSD neutralizer technology intended to shorten and stop the effects of an LSD trip during a therapy session in collaboration with the University Hospital Basel's Liechti Lab.
Acquired the exclusive license to 8 clinical trials and human safety studies of LSD at University Hospital Basel evaluating LSD.
Filed a patent application and are developing technologies and analytics that seek to personalize LSD assisted therapy experiences for a specific patient in collaboration with University Hospital Basel Liechti Lab.

Microdosing Division
Entered into a clinical trial agreement with Maastricht University to undertake a Phase 2a clinical trial for microdosing LSD in adult patients with ADHD intending to begin by the end of 2020.
Appointed Principal Investigators for Phase 2a clinical trial for microdosing LSD Dr Kim Krupyers (Maastricht University) and Dr Matthias Liechti (University Hospital Basel).
Added additional clinical trial site at University Hospital Basel for Phase 2a clinical trial at University Hospital Basel.

18-MC (Opioid Use Disorder Program)
Initiated and began dosing of a Phase 1 human safety trial of our 18-MC program for Opioid Use Disorder in Australia in the midst of COVID-19.

MDMA (3,4-Methylenedioxymethamphetamine)
A
cquired the exclusive license to 9 completed clinical trials of MDMA at University Hospital Basel. Performing ongoing evaluation of data and opportunities to create new drug development programs to include MDMA
Filed a patent application and are developing technologies and analytics that seek to personalize MDMA assisted therapy experiences for a specific patient in collaboration with University Hospital Basel Liechti Lab.

DMT (N,N-Dimethyltryptamine, active ingredient in Ayahuasca)
Providing startup funding to Liechti Lab for a Phase 1 clinical trial of DMT testing various intravenous dosing regimens, expected to begin in Q4 of 2020 setting stage for future potential Phase 2a proof of concept trials

Corporate Development
Appointed Johns Hopkins Professor and leading psychedelics researcher, Matt Johnson to its scientific advisory board

MindMed Co-Founders and Co-CEOs will provide an update on operations and corporate activities, and will answer questions for shareholders on Thursday, July 2 at 1pm EST. Please sign up for Webinar here:

https://us02web.zoom.us/webinar/register/WN_pOzqk58eQaqgq_UZExDiHg

When: Jul 2, 2020 01:00 PM Eastern Time (US and Canada)
After registering, you will receive a confirmation email containing information about joining the webinar.

About MindMed

Mind Medicine (MindMed) Inc. is a neuro-pharmaceutical company that discovers, develops and deploys psychedelic-inspired medicines to improve health, promote wellness and alleviate suffering. The company's has initiated or is initiating studies to evaluate potential treatments to help patients with ADHD, anxiety, cluster headaches and substance abuse. The MindMed executive team brings extensive biopharmaceutical industry experience to this groundbreaking approach to the development of next-generation psychedelic medicines. MindMed trades on the NEO Exchange under the symbol MMED. MindMed can also be traded in the US under the symbol OTC: MMEDF and in Germany under the symbol DE:BGHM. For more information: www.mindmed.co.

MindMed Forward-Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Mind Medicine (MindMed) Inc. ("MindMed" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying word. These statements concern, and these risks and uncertainties include, among others, MindMed's and its collaborators' ability to continue to conduct research and clinical programs (including those discussed in this press release), MindMed's ability to manage its supply chain, net product sales of products marketed by MindMed and/or its collaborators (collectively, "MindMed's Products"), and the global economy; the nature, timing, and possible success and therapeutic applications of MindMed's Products and product candidates and research and clinical programs now underway or planned; the likelihood, timing, and scope of possible regulatory approval and commercial launch of MindMed's product candidates and new indications for MindMed's Products; unforeseen safety issues resulting from the administration of MindMed's Products and product candidates in patients, including serious complications or side effects in connection with the use of MindMed's Products and product candidates in clinical trials; determinations by regulatory and administrative governmental authorities which may delay or restrict MindMed's ability to continue to develop or commercialize MindMed's Products and product candidates; ongoing regulatory obligations and oversight impacting MindMed's Products, research and clinical programs, and business, including those relating to patient privacy; uncertainty of market acceptance and commercial success of MindMed's Products and product candidates and the impact of studies (whether conducted by MindMed or others and whether mandated or voluntary) on the commercial success of MindMed's Products and product candidates; the availability and extent of reimbursement of MindMed's Products from third-party payers, including private payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and government programs such as Medicare and Medicaid; coverage and reimbursement determinations by such payers and new policies and procedures adopted by such payers; competing drugs and product candidates that may be superior to MindMed's Products and product candidates; the extent to which the results from the research and development programs conducted by MindMed or its collaborators may be replicated in other studies and lead to therapeutic applications; the ability of MindMed to manufacture and manage supply chains for multiple products and product candidates; the ability of MindMed's collaborators, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labelling, distribution, and other steps related to MindMed's Products and product candidates; unanticipated expenses; the costs of developing, producing, and selling products; the ability of MindMed to meet any of its financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license or collaboration agreement to be cancelled or terminated without any further product success; and risks associated with intellectual property of other parties and pending or future litigation relating thereto, other litigation and other proceedings and government investigations relating to the Company and/or its operations, the ultimate outcome of any such proceedings and investigations, and the impact any of the foregoing may have on MindMed's business, prospects, operating results, and financial condition. Any forward-looking statements are made based on management's current beliefs and judgment, and the reader is cautioned not to rely on any forward-looking statements made by MindMed. MindMed does not undertake any obligation to update publicly any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise.

Media Contact: Anna Walsh
E: mindmedpr@pacepublicrelations.com
P: 212-254-4730

Investor Relations: invest@mindmed.co

SOURCE Mind Medicine (MindMed) Inc.
Related Links

https://www.mindmed.co/


Organization Profile

Mind Medicine (MindMed) Inc.


Also from this source


MindMed Developing IP For Personalized Psychedelic Assisted...


MindMed To Evaluate Ayahuasca's Active Ingredient DMT In Phase 1...


Phase 2 Clinical Trial of LSD for "Suicide Headaches" Begins...
HUAWEI QUOTES BOLTONNew book reveals Trump sees Meng arrest as about leverage, not justice

Huawei Canada

Statement from Huawei Canada:

MARKHAM, ON, June 28, 2020 /CNW/ - The new book by Donald Trump's former National Security Advisor reveals that, from the start, the President of the United States viewed the arrest and detention of Meng Wanzhou, Chief Financial Officer of Huawei, as a way of exerting political leverage – not as a matter of justice.

In The Room Where it Happened, John Bolton writes: "At the December 7 [2018] White House Christmas dinner, Trump raised Meng's arrest, riffing about how much pressure this put on China."

According to Bolton, Trump viewed Ms. Meng as a prominent Chinese citizen – "the Ivanka Trump of China," in the President's words – whose freedom could be a powerful bargaining chip in trade negotiations with China. As Bolton puts it: "…Trump believed everything was open in trade negotiations."

Bolton's recollection of events is supported by Trump's own public comments days after Ms. Meng's arrest: He said he would interfere politically in the case if it helped the U.S.-China relationship. "If I think it's good for what will be certainly the largest trade deal ever made – which is a very important thing – what's good for national security, I would certainly intervene if I thought it was necessary," the President said in December 2018.

In Donald Trump's eyes the charges against Ms. Meng have always been a bargaining chip to be used to negotiate a trade deal with China and enhance his chances at re-election in November.

This reckless and unethical perspective has left the government of Canada in an extremely difficult situation – caught in the middle of an escalating dispute between two global powers.

It is the duty of the President of the United States to uphold the law – not to manipulate it for his own political benefit. We call on the Trump administration to immediately withdraw the charges against Meng Wanzhou.

SOURCE Huawei Canada

Organization Profile

Huawei Canada


Also from this source


Huawei Canada spokesperson provides the following statement...


Huawei Statement Regarding the UK Government's 5G Decision...


Huawei Canada Statement Regarding Meng Wanzhou Cas
FUEL CELLS (CDN) VS ELECTRIC (TESLA)
Ballard Applauds Landmark Zero-Emission Trucks Regulation in California 


Ballard Power Systems Inc.

Fuel cell solutions offer a compelling value proposition for trucks

VANCOUVER, BC, June 29, 2020 /CNW/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today recognized the landmark Advanced Clean Truck Regulation passed by the California Air Resources Board (CARB), requiring the scaled adoption of zero-emission commercial trucks in California.

On June 25, 2020 CARB adopted a first-in-the-world regulation requiring truck manufacturers to transition from diesel trucks and vans (for Class 2b through Class 8) to electric zero-emission trucks, with a plan for every new truck sold in California to be zero-emission by 2045.

Manufacturers who certify medium- and heavy-duty chassis or complete vehicles with combustion engines are now required to sell zero-emission trucks as an increasing percentage of their annual sales in California, starting in 2024. For model year 2024, 9% of all on-road Class 4-8 truck sales must be zero-emission vehicles, incrementally scaling up to 50% for 2030, and 75% for 2035 and beyond. Similarly, for Class 7-8 tractors the requirements are 5% for 2024, 30% for 2030, and 40% for 2035.

Sales requirements for Class 7-8 tractors under this regulation create alignment with the Clean Air Action Plan encompassing the Ports of Los Angeles and Long Beach, which has a goal of reducing pollution from every source at the ports. Sources include ships, trains, harbor craft, cargo-handling equipment, along with 16,000 Class 8 drayage trucks currently operating at these ports.

"This bold zero-emission trucks regulation recognizes that, although trucks represent just 7% of all registered vehicles in California, they are responsible for 70% of the state's smog-causing pollution and 80% of carcinogenic diesel soot," said Randy MacEwen, Ballard President and CEO. "The Advanced Clean Truck Regulation puts California on an aggressive path toward implementation of clean energy transportation solutions for medium and heavy-duty trucks – market segments for which emissions abatement has previously proven difficult to achieve. We believe hydrogen-powered fuel cells will uniquely enable the decarbonization of heavy and long-range commercial trucks, with clear range and refueling advantages over battery electric trucks and without compromises to payload."

Tim Sasseen, Ballard's Business Development Manager for California stated, "We commend CARB for its continued strong leadership in reducing emissions and improving air quality. At Ballard, we are dedicated to offering a compelling portfolio of fuel cell products to accelerate the commercialization of fuel cell trucks in California. We are initially focused on market segments that feature heavy trucks with long daily range requirements and a return-to-base depot refueling model, with longer-term markets that feature corridor refueling. We are making progress on current and planned fuel cell truck demonstration programs to support California in meetings its zero-emission trucks mandates."

Ballard's industry leading fuel cell technology currently supports the operation of over 2,200 commercial trucks, primarily in China. Ballard estimates the total global addressable market for fuel cell engines in commercial trucks at more than $120 billion annually.

About Ballard Power Systems
Ballard Power Systems' (NASDAQ: BLDP;TSX: BLDP) vision is to deliver fuel cell power for a sustainable planet. Ballard zero-emission PEM fuel cells are enabling electrification of mobility, including buses, commercial trucks, trains, marine vessels, passenger cars, forklift trucks and UAVs. To learn more about Ballard, please visit www.ballard.com.

This release contains forward-looking statements concerning anticipated product performance and other characteristics, product deliveries and deployments. These forward-looking statements reflect Ballard's current expectations as contemplated under section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any such forward-looking statements are based on Ballard's assumptions relating to its financial forecasts and expectations regarding its product development efforts, manufacturing capacity, and market demand.

These statements involve risks and uncertainties that may cause Ballard's actual results to be materially different, including general economic and regulatory changes, detrimental reliance on third parties, successfully achieving our business plans and achieving and sustaining profitability. For a detailed discussion of these and other risk factors that could affect Ballard's future performance, please refer to Ballard's most recent Annual Information Form. Readers should not place undue reliance on Ballard's forward-looking statements and Ballard assumes no obligation to update or release any revisions to these forward looking statements, other than as required under applicable legislation.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities. The Ballard Common Shares have not been registered under the United States Securities Act of 1933, as amended, or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

SOURCE Ballard Power Systems Inc.

For further information: Guy McAree, +1.604.412.7919, media@ballard.com or investors@ballard.com
Related Links

www.ballard.com


Organization Profile



Ballard Power Systems Inc.
More Canadians are worrying about the economy and over half are cutting discretionary spending: CIBC  Poll

Longer term financial impact of the COVID-19 pandemic beginning to show in Canadians' financial plans; saving money and avoiding debt are now top goals


TORONTO, June 29, 2020 /CNW/ - COVID-19's impact on the economy is causing many Canadians to worry about the future: 79 per cent of respondents in CIBC's Financial Priorities Poll say they are concerned about continued recessionary times next year, compared to 55 per cent who said they feared an economic downturn in a December 2019 survey.

Economic worries may be a factor in why many Canadians are adjusting their financial habits.

CIBC Poll (CNW Group/CIBC)



Many respondents (63 per cent) say they have significantly cut down on discretionary spending and more than half (55 per cent) agree they need to get a better handle on their finances this year.

"It's understandable that Canadians are worried about the economy and are feeling uncertain about the impact on their ambitions, but this is a time when good financial advice conversations are most valuable, including assessing your overall situation, looking at opportunities to improve cash flow, and adjusting your financial plan if necessary," said Laura Dottori-Attanasio, Group Head, Retail and Business Banking, CIBC. "It's a positive sign that many Canadians are taking a responsible approach to the situation by making changes to their spending and working to limit unnecessary debt. Good cash flow management now can help you through the current situation, and over the longer term free up funds to divert towards savings or other goals."

The survey also found that 46 per cent of Canadians say the economic impact of the pandemic has adversely affected their finances and a similar number (47 per cent) feel it will take more than a year to get their personal finances back on track. Canadians are prioritizing building an emergency fund in 2020, citing this as a top goal for the remainder of the year, followed by steering clear of adding on debt. Of the 22 per cent of respondents who've had to borrow more in the past 12 months, the number one reason was for day-to-day items (38 per cent) followed by a loss of income (28 per cent).

"The impact of the pandemic will be felt by Canadians for some time. While we have a long way to go to get back to a normal economy, taking charge of your finances now with a savings and debt management plan is an important step towards putting your personal finances back on track," added Ms. Dottori-Attanasio.

The survey also found:
Top financial goals for the remainder of 2020 are: generally saving as much as possible (37 per cent), and avoiding taking on more debt (36 per cent)
Close to three-fourths of Canadians (74 per cent) say the uncertainty of the current environment makes it difficult to plan ahead, and over half (54 per cent) are generally worried about their financial future
The number of people who say they've taken on more debt is lower (22 per cent) than in December 2019 (28 per cent). Among those who have taken on more debt, 38 per cent say they did so to cover day-to-day expenses or due to loss of income (28 per cent) and job loss (18 per cent, +9 per cent from December 2019)
Regionally, the poll found differences in how Canadians are tightening their wallets. Residents in the Prairies say they are cutting discretionary spending the most, led by 76 per cent of those in Saskatchewan and Manitoba, and 69 per cent of Albertans, compared to the national average of 63 per cent
At 58 per cent, taking on more debt to pay for day-to-day items was the highest in British Columbia, 20 per cent higher than the national average of 38 per cent

Disclaimer

From June 8th to June 9th 2020 an online survey of 1,517 randomly selected Canadian adults who are Maru Voice Canada panelists was executed by Maru/Blue. For comparison purposes, a probability sample of this size has an estimated margin of error (which measures sampling variability) of +/- 2.5%, 19 times out of 20. The results have been weighted by education, age, gender and region (and in Quebec, language) to match the population, according to Census data. This is to ensure the sample is representative of the entire adult population of Canada. Discrepancies in or between totals are due to rounding.

About CIBC

CIBC is a leading Canadian-based global financial institution with 10 million personal banking, business, public sector and institutional clients. Across Personal and Business Banking, Commercial Banking and Wealth Management, and Capital Markets businesses, CIBC offers a full range of advice, solutions and services through its leading digital banking network, and locations across Canada, in the United States and around the world. Ongoing news releases and more information about CIBC can be found at www.cibc.com/en/about-cibc/media-centre.html.




ON THE ROAD TO SOCIALIZING CAPITALISM
The DUCA Impact Lab and the School for Social Entrepreneurs in Canada build an international PPE supply chain specifically for local community agencies


The DUCA Impact Lab

TORONTO, June 29, 2020 /CNW/ - As Ontario begins to loosen restrictions, a group of social-service agencies have a new source of personal protective equipment thanks to the efforts of an informal network of far-flung volunteers, businesses, and organizations.

This initiative addresses a key gap in PPE supply efforts throughout the COVID-19 crisis — providing PPE for people who work in essential community services such as women's and homeless shelters, meal programs, and drop-ins, among others.

Unlike other services, including hospitals and long-term care homes, many social-service organizations weren't prepared with PPE on hand and, amid a global surge in demand, had little hope of getting any. Governments have not stepped up fast enough. Agencies have been faced with the impossible choice to stop essential services, scale back, or operate with less PPE than they should.

That's why staff at the School for Social Entrepreneurs (SSE) in Canada reached out to the School's local community and their contacts across continents to create a new PPE supply chain leveraging the BMW Foundation Herbert Quandt's Responsible Leaders Network and the League of Intrapreneurs.

"All these private citizens said, 'Not on my watch,' Marjorie Brans, Director of Impact at SSE says. Ordinary people all over the world wanted to do something to help when COVID-19 hit. On their own, they felt helpless, but by working together in a network they were able to make a difference for people who have been overlooked during this crisis. This is the everyday leadership we need"

DUCA Financial Services Credit Union, through its charitable foundation, the DUCA Impact Lab, donated the cash to help kickstart the initiative and purchase the supplies, including gloves, masks, and gowns. "DUCA is delighted to donate to support this impactful and timely initiative which very much aligns with DUCA's purpose to help People do more, be more and achieve more especially during these times" says Doug Conick, President & CEO of DUCA Credit Union and Chair of the DUCA Impact Lab.

"This is a global network that came together in the face of so many challenges. It's an example of the creative ingenuity brought to light by the crisis, and a refreshing reminder that interdependence with the global community can solve local challenges," Keith Taylor, Executive Director of DUCA Impact Lab, says.

Mobile Medics International, a non-profit that provides medical aid during humanitarian crises and health care to underserved populations, helped procure the PPE. Founder Teresa Gray says when it comes to social-service workers, "In the face of COVID, unrecognized means under-protected."

West Neighbourhood House, a non-profit multi-service agency in west Toronto, was one of the recipients.

"Thanks to DUCA Credit Union, the DUCA Impact Lab and these incredible volunteers, we have PPE to keep our Personal Support Workers safe as they work in the homes of seniors; and our drop-in workers safe as they maintain support and connections with homeless people. It's not medical care, but it's essential care," Executive Director Maureen Fair says.

Fair praised the volunteers who worked together across multiple time zones for weeks to comb the globe for sources of PPE. A BMW Foundation Responsible Leader in India was even inspired to transform his family's clothing factory, the Signet Group, to make PPE.

The gift from DUCA Credit Union was managed through through the Maitri Platform International Project Fund at Charities Aid Foundation (CAF) Canada, which helps Canadians to support charitable projects around the world. To contribute to the fund or learn more, visit the page on CanadaHelps.

About DUCA Financial Services Credit Union:
DUCA Financial Services Credit Union Ltd. (DUCA) was formed in 1954 and has grown from a single branch Credit Union in Toronto to branches across the GTA and Central Ontario with over 70,000 Members. DUCA provides comprehensive banking services to both individuals and businesses through an innovative Co-Operative Banking model. With no-fee banking, attractive mortgage and lending rates, a Profit Sharing program that rewards Members, and a commitment to communities through the DUCA Impact Lab, DUCA is an excellent alternative to traditional banking institutions. For more information visit www.duca.com.

About West Neighbourhood House:
West Neighbourhood House is a non-profit multi-service community organization serving all age groups and the diverse populations of downtown west Toronto. West NH has continued to provide in-person care to local seniors in their homes with dedicated Personal Support Workers and Meals on Wheels. West NH's drop-in for homeless people has also stayed open to provide basic needs such as toilets, showers, laundry, telephone and internet as well as case management and advocacy for housing, income supports, treatment programs, legal help and medical care. Learn more at: http://www.westnh.org/

About Mobile Medics International:
Mobile Medics International (MMI) is a 501(C)3 non-profit, volunteer organization that provides medical care to victims of natural disaster and humanitarian crises. MMI was founded to provide basic healthcare to those who may not be able to access medical facilities in a disaster or those who are medically underserved. As its name implies, MMI is a mobile team that specializes in reaching patients in remote areas. From weather-related catastrophes to refugee crises worldwide, MMI volunteers are ready to respond and help those affected. Learn more at: https://www.mobilemedicsinternational.org/

About the School for Social Entrepreneurs Canada:
A project of MakeWay's Shared Platform, The School for Social Entrepreneurs is a global leader in activating people and organizations to make positive social and environmental change by contributing to the achievement of the United Nations Sustainable Development Goals by 2030. SSE works with executives, entrepreneurs, intrapreneurs, change makers, rebels, boat-rockers, and anyone who wants to disrupt the status quo for a more equitable and just world. Learn more at: www.the-sse.ca

SOURCE The DUCA Impact Lab

For further information: Marjorie Brans, mbrans@sseontario.org
Related Links

https://ducaimpactlab.com/


Organization Profile

The DUCA Impact Lab

Kaddish - Ofra Haza עפרה חזה קדיש


Why do I cry at night?
Oh why do I feel so bad? Something holds me tight It's something in the air. I have a prayer, a prayer, A prayer from my heart Night after night after daylight, Memories of home... בְּחַיֵּיכוֹן וּבְיוֹמֵיכוֹן - קַדִּישׁ⁠ עַל יִשְׂרָאֵל תַּלְמִידֵיהוֹן - קַדִּישׁ⁠ עַל נֶחָמָה עַל שֵׁיזָבָא - קַדִּישׁ⁠ עַל רְפוּאָה וּגְאֻלָּה - קַדִּישׁ⁠ עַל סְלִיחָה וְכַפָּרָה - קַדִּישׁ⁠ עַל הַצָּלָה עַל הַצָּלָה - קַדִּישׁ⁠ עַל נֶחָמָה - קַדִּישׁ⁠ עַל רְפוּאָה - קַדִּישׁ⁠ עַל סְלִיחָה - קַדִּישׁ⁠ וְכַפָּרָה עַל הַצָּלָה עַל הַצָּלָה - קַדִּישׁ⁠ אוֹ - קַדִּישׁ דְּרַבָּנָן אוֹ - קַדִּישׁ דַּאֲמִירָן בְּעָלְמָא דִּי בְרָא - קַדִּישׁ⁠ הוּא יִתְגַּדַּל וְיִתְקַדַּשׁ - קַדִּישׁ⁠ עַל נֶחָמָה עַל שֵׁיזָבָא - קַדִּישׁ⁠ עַל רְפוּאָה וּגְאֻלָּה - קַדִּישׁ⁠ בְּחַיֵּיכוֹן וּבְיוֹמֵיכוֹן - קַדִּישׁ⁠ עַל יִשְׂרָאֵל תַּלְמִידֵיהוֹן - קַדִּישׁ⁠ עַל שְׁלָמָא - קַדִּישׁ⁠ מִן שְׁמַיָּא - קַדִּישׁ⁠ יְהֵא לָנָא - קַדִּישׁ⁠ וְכַפָּרָה עַל הַצָּלָה עַל הַצָּלָה - קַדִּישׁ⁠ Bachayechon uvyomechon - kaddish Al Israel talmidehon - kaddish Al nachamoh al sheizovo - kaddish Al rafuoh uge'uloh - kaddish Al salichoh wachaporoh - kaddish Al hasoloh al hasoloh - kaddish Al nachomoh - kaddish Al rafuoh - kaddish Al salichoh - kaddish Wachaporoh al hasoloh al hasoloh - kaddish Oh - Kaddish de'rabanan Oh - Kaddish da'amiran Ba'olamo di voro - kaddish Huyitgadal weyitkadash - kaddish Al nachamoh al sheizovo - kaddish Al rafuoh uge'uloh - kaddish Bachayechon uvyomechon - kaddish Al Israel talmidehon - kaddish Al shalomo - kaddish Min shamayo - kaddish Yehe lano - kaddish Wachaporoh al hasoloh al hasoloh - kaddish M'yiten shama'i keri'oh Hamah gurah v'hamaym ka li retoh Ha samovim rachu'ah Hamah hareh 'al kah teru'ah For salvation, Kaddish, For redemption, Kaddish, For forgiveness, Kaddish, For health, Kaddish, For all the wars victims, Kaddish, For all the holocaust victims, Kaddish Why do I cry at night? Why do I feel so bad? Something holds me tight It's something in the air. I have a prayer, a prayer, A prayer from my heart Night after night after daylight, Memories of home...